Susquehanna International Group, LLP Denali Therapeutics Inc. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 60,398 shares of DNLI stock, worth $1.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,398

Previous 104,640 42.28%

Holding current value

$1.73 Million

Previous $2.15 Million 34.7%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$14.96 - $23.22 $661,860 - $1.03 Million	-44,242 Reduced 42.28%	60,398 $1.4 Million
Q1 2024 May 07, 2024	BUY	$15.83 - $23.35 $692,182 - $1.02 Million	43,726 Added 71.78%	104,640 $2.15 Million
Q4 2023 Feb 14, 2024	SELL	$16.2 - $23.18 $532,801 - $762,367	-32,889 Reduced 35.06%	60,914 $1.31 Million
Q3 2023 Nov 14, 2023	SELL	$20.63 - $30.17 $490,767 - $717,714	-23,789 Reduced 20.23%	93,803 $1.94 Million
Q2 2023 Aug 11, 2023	SELL	$23.37 - $32.96 $5.21 Million - $7.35 Million	-222,972 Reduced 65.47%	117,592 $3.47 Million
Q1 2023 May 16, 2023	BUY	$21.91 - $32.67 $6.95 Million - $10.4 Million	317,311 Added 1364.6%	340,564 $7.85 Million
Q4 2022 Feb 14, 2023	SELL	$26.28 - $33.92 $1.93 Million - $2.49 Million	-73,374 Reduced 75.94%	23,253 $646,000
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $2.24 Million - $3.32 Million	86,101 Added 817.98%	96,627 $2.97 Million
Q2 2022 Aug 15, 2022	SELL	$20.88 - $35.19 $1.57 Million - $2.65 Million	-75,192 Reduced 87.72%	10,526 $310,000
Q1 2022 May 16, 2022	SELL	$29.0 - $47.27 $962,133 - $1.57 Million	-33,177 Reduced 27.9%	85,718 $2.76 Million
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $2.84 Million - $3.68 Million	66,798 Added 128.22%	118,895 $5.3 Million
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $1.59 Million - $2.57 Million	32,872 Added 170.99%	52,097 $2.63 Million
Q2 2021 Aug 11, 2021	BUY	$50.3 - $78.44 $206,280 - $321,682	4,101 Added 27.12%	19,225 $1.51 Million
Q1 2021 May 17, 2021	SELL	$53.8 - $81.53 $537,784 - $814,973	-9,996 Reduced 39.79%	15,124 $864,000
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $322,307 - $817,433	8,737 Added 53.33%	25,120 $2.1 Million
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $85,581 - $143,708	3,700 Added 29.17%	16,383 $587,000
Q2 2020 Aug 14, 2020	SELL	$16.01 - $28.82 $439,330 - $790,849	-27,441 Reduced 68.39%	12,683 $307,000
Q1 2020 May 15, 2020	SELL	$14.2 - $27.98 $280,137 - $551,989	-19,728 Reduced 32.96%	40,124 $703,000
Q3 2019 Nov 14, 2019	BUY	$15.32 - $21.92 $335,921 - $480,639	21,927 Added 57.82%	59,852 $917,000
Q2 2019 Aug 16, 2019	BUY	$18.5 - $28.14 $437,710 - $665,792	23,660 Added 165.86%	37,925 $787,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $263,902 - $401,417	14,265 New	14,265 $296,000

Others Institutions Holding DNLI

# of Institutions

214

Shares Held

121M

Call Options Held

127K

Put Options Held

38.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.85B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Denali Therapeutics Inc. Transaction History